Learn everything you need to know about Cisatracurium Besylate-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, ...

Atracurium besylate 10mg/mL; soln for IV inj. <1month: not recommended. Individualize. 1month to 2yrs (under halothane anesthesia): initially 0.3–0.4mg/kg. ≥2yrs: initially 0.4–0.5mg/kg IV bolus.

Objective: The aim of this study was to compare the antihypertensive efficacy and tolerability of the calcium channel antagonist amlodipine besylate versus the angiotensin II type 1 receptor ...

Amlodipine oral tablet contains the active drug amlodipine besylate. It’s classified as a calcium channel blocker. If you have certain heart conditions, your doctor may prescribe amlodipine oral ...

Review the side-effects of Cisatracurium Besylate as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In ...

Hikma is offering cisatracurium besylate injection in 200mg/20ml and 20mg/10ml doses. The product is indicated as an adjunct to general anesthesia to facilitate tracheal intubation in adults and in ...

NEW DELHI: Drug major Aurobindo Pharma has received final approval from the US health regulator to manufacture and market Atracurium Besylate injections in the American market. "The company has ...

At present, the company has 11 ANDAs approved out of its Unit IV formulation facility in Hyderabad, manufacturing general injectable products, Aurbindo Pharma added. Aurobindo Pharma shares were ...